Table 1 The clinical and histological characteristics of each clusters
From: Expression and prognostic value of cell-cycle-associated genes in gastric adenocarcinoma
Cluster | 1 | 2 | 3 | 4 | 5 | P-value | Correlation coefficient | |
|---|---|---|---|---|---|---|---|---|
(n = 15) | (n = 10) | (n = 47) | (n = 63) | (n = 71) | ||||
Age (mean) | 62.7 | 64.1 | 67.2 | 65.2 | 63.6 | 0.406 | −0.061 | |
Gender | Male | 12 | 7 | 25 | 42 | 40 | 0.255 | 0.178c |
Female | 3 | 3 | 22 | 21 | 31 | |||
Race | Asian | 5 | 3 | 12 | 9 | 15 | 0.309 | 0.093 |
White | 10 | 7 | 30 | 47 | 49 | |||
Black | 0 | 0 | 3 | 1 | 0 | |||
NAa | 0 | 0 | 2 | 6 | 7 | |||
Grade | G1 | 0 | 0 | 0 | 0 | 3 | 0.104 | 0.178c |
G2 | 6 | 2 | 14 | 12 | 6 | |||
G3 | 9 | 8 | 32 | 50 | 60 | |||
GX | 0 | 0 | 1 | 1 | 2 | |||
Histological diagnosis (GAC) | Signet ring type | 1 | 0 | 2 | 2 | 6 | / | / |
Diffuse type | 2 | 2 | 10 | 18 | 34 | |||
NOSb | 12 | 8 | 35 | 43 | 31 | |||
History of other malignancy | Yes | 1 | 0 | 1 | 1 | 4 | 0.595 | −.057 |
No | 14 | 10 | 46 | 62 | 67 | |||
Neoadjuvant therapy | Yes | 0 | 0 | 0 | 0 | 0 | / | / |
No | 15 | 10 | 47 | 63 | 71 | |||
Tumor pathologic (AJCC PT) | T1 | 1 | 0 | 1 | 3 | 1 | 0.136 | .089 |
T2 | 3 | 1 | 13 | 16 | 11 | |||
T3 | 8 | 5 | 15 | 34 | 30 | |||
T4 | 3 | 4 | 18 | 10 | 29 | |||
Nodes pathologic (AJCC PN) | N0 | 6 | 3 | 25 | 24 | 17 | 0.009 | 0.165c |
N1 | 4 | 4 | 7 | 17 | 20 | |||
N2 | 1 | 2 | 8 | 7 | 15 | |||
N3 | 3 | 0 | 7 | 15 | 19 | |||
NX | 1 | 1 | 0 | 0 | 0 | |||
Metastasis pathologic (AJCC PM) | M0 | 14 | 10 | 43 | 56 | 61 | 0.211 | 0.093 |
M1 | 0 | 0 | 0 | 6 | 7 | |||
MX | 1 | 0 | 4 | 1 | 3 | |||
Tumor stage | Stage I | 1 | 0 | 10 | 11 | 5 | 0.006 | 0.252d |
Stage II | 9 | 8 | 20 | 25 | 20 | |||
Stage III | 4 | 2 | 17 | 20 | 38 | |||
Stage IV | 1 | 0 | 0 | 7 | 8 | |||